AI Leadership Insights

By Prof. May El Barachi, Dean of Computer Science, University of Wollongong in Dubai. Published 14 November 2025. 

AI in healthcare is reshaping how care is delivered - automating routine tasks, sharpening diagnostic accuracy, and enabling proactive care from wearables to genomics. Real gains are already documented: ambient scribes cutting documentation time up to 70%, predictive analytics reducing emergency visits by 68%, clinical chatbots cutting readmissions by 30%. 

What is AI doing in healthcare today? 

Artificial intelligence is reshaping healthcare by automating routine tasks, enhancing diagnostic accuracy, and enabling proactive care, all while aiming to make complex technological solutions accessible and understandable. Drawing from recent advancements as of 2025, AI is not just a tool but a transformative force that predicts, learns, and acts to reinvigorate modern medicine - from linking genetic codes to powering robotic assistants in surgery. 

Across patients, clinicians, and administrators, AI simplifies operations, often completing human-like tasks more efficiently and cost-effectively. 

However, AI offers tremendous promise only if it is implemented with careful consideration of ethical issues such as data bias and privacy, to ensure equitable benefits. The sections below expand on key examples with real-world applications and emerging trends. 

How does AI improve early disease detection? 

AI excels in early detection by processing signals from wearables or imaging devices to flag potential issues before they escalate. 

For someone predisposed to conditions like cardiovascular disease, epilepsy, or diabetes, a smartwatch or sensor can monitor heart rate, blood sugar, or neurological patterns in real time. An AI model then analyzes this data to predict silent heart attacks, strokes, or seizures, alerting users or doctors promptly. 

Beyond wearables, AI interprets brain scans with remarkable precision: trained on thousands of images, it can detect stroke timing twice as accurately as human experts, enabling faster interventions that save lives. In orthopedics, AI reviews X-rays to identify fractures that might be overlooked - up to 10% of cases by radiologists - minimizing errors and reducing the need for follow-up scans. 

In disease surveillance, AI models trained on population data can predict over 1,000 conditions, such as Alzheimer's or kidney disease, years in advance by spotting subtle patterns in MRIs or health records. These capabilities are particularly valuable in under-resourced areas, where AI augments limited specialist availability. 

How does AI support remote monitoring for chronic conditions? 

For patients with ongoing illnesses, AI enables continuous oversight without constant hospital visits. 

Sensors in devices track vital signs, movement, or even cough patterns, feeding data into models that detect anomalies - a sudden drop in oxygen levels for COPD patients, or mood shifts relevant to mental health. Proactive alerts can summon help during episodes such as falls or irregular heartbeats, improving quality of life for the elderly and those in remote locations. 

Tools like AI-powered apps for chronic cough analysis and platforms that reduce emergency visits by 68% through predictive analytics exemplify this approach, allowing healthcare teams to intervene early and optimize resource use. This cuts costs and empowers patients with self-management insights, though integration with human care remains essential to address false positives. 

How is AI accelerating medicine development? 

AI revolutionizes drug discovery by simulating molecular interactions at speeds impossible for humans. 

By inputting vast datasets on chemical behaviors, disease pathways, and past trials, models predict effective compound combinations for specific conditions, slashing development timelines from years to months. Generative AI further innovates by creating synthetic datasets for rare diseases or modeling drug efficacy, as seen in platforms that simulate personalized treatment responses. 

In 2025, this has led to breakthroughs in targeted therapies, such as AI-optimized vaccines or antivirals, with tools reducing clinical trial failures by identifying viable candidates early. Collaboration with traditional research ensures safety: AI complements rather than replaces expert oversight. 

What other applications of AI are emerging in healthcare? 

Beyond detection, monitoring, and drug discovery, AI is reaching into administration, training, and patient support. 

• Documentation: ambient scribe tools transcribe consultations using speech recognition and NLP, cutting documentation time by up to 70% and giving doctors more face-time with patients. 

• Clinical chatbots: powered by retrieval-augmented generation, they answer medical queries accurately 58% of the time, guide decisions, and reduce readmissions by 30%. 

• Medical education: AI simulates patient scenarios for training, providing personalized feedback to students. 

• Mental health support: 24/7 chatbots offer support, tracking symptoms and suggesting coping strategies. 

• Ambulance triage: AI assesses patient needs with 80% accuracy based on vitals and history, aiding paramedics. 

• Traditional medicine integration: AI catalogs indigenous knowledge to discover new compounds, blending ancient wisdom with modern tech. 

How is AI enabling personalized medicine? 

AI and machine learning tackle the overwhelm of vast, varied datasets that doctors face daily. Traditional analysis of records, images, and histories is time-consuming, but deep learning models excel at processing unstructured data - radiology scans, blood tests, EKGs, genomics, and patient histories. This provides real-time insights, such as flagging abnormalities in images or correlating symptoms with underlying causes, enhancing diagnostic speed and accuracy. 

Precision medicine takes this further by customizing treatments to patient subgroups rather than a blanket approach. For ovarian cancer, machine learning analyzed 32 blood markers to identify early-stage patients with poor prognoses, uncovering hidden disease groups and guiding targeted therapies. This data-driven method reveals interactions between variables that hypothesis-based research might miss, especially in multifactorial diseases. 

AI also predicts drug responses via genetic markers, optimizes dosages to minimize side effects, and reshapes clinical decisions for conditions like autoimmune disorders or cancer. Additional advancements include AI for diabetic retinopathy - models that screen retinal images instantly, reducing wait times from weeks to minutes in underserved areas. In genomics, AI interprets sequences to inform therapy, as in pediatric brain tumors where it identifies subgroups amenable to less invasive treatments, avoiding long-term side effects. For cardiovascular risks, AI combines electronic health records with genetics for better predictions. Environmental factors are integrated too, with AI forecasting outbreaks or toxin exposures. 

Challenges like data bias persist, but synergies between AI and human expertise promise more equitable, effective care. 

What guardrails matter so innovation scales safely? 

• Data quality and governance: unify sources, define stewardship, monitor drift. 

• Bias and equity: validate across demographics; track outcomes, not just accuracy. 

• Privacy and security: least-privilege access, auditability, and privacy-preserving options. 

• Clinical integration: design for the last mile - alert-fatigue control, clear accountability, human oversight. 

• Change management: upskill clinicians, update SOPs, and align incentives to value-based care. 

What should healthcare leaders do next? 

• Start where data is strong (imaging, triage, documentation).

• Pick two or three high-impact use cases with measurable KPIs (time-to-diagnosis, readmissions, clinician minutes saved). 

• Build the platform, not one-offs: interoperability, monitoring, model registry, reuse. 

• Establish an AI governance council (clinicians, data, legal, ethics, patient reps).

• Invest in skills: clinicians fluent in data; pharmacists and nurses comfortable with AI tools; engineers who understand clinical workflows. 

A 30-day quick win 

• Pilot an ambient scribe in one clinic; measure note time, after-hours charting, and clinician satisfaction. 

• Add a radiology-assist model for one indication, for example fracture detection; track sensitivity, specificity, and secondary reads saved. 

• Stand up a lightweight AI registry and monitoring dashboard (ownership, versioning, metrics, drift alerts). 

Closing thought 

AI in healthcare is not about replacing clinicians - it is about amplifying them. The future of care will be defined not by the machines we build, but by how we use them: to heal, to connect, and to make high-quality care accessible to more people. 

FAQ

Q. Will AI replace doctors?
A. No. The pattern across deployments is amplification, not replacement: ambient scribes free clinician time, imaging assists catch overlooked findings, chatbots triage routine queries. Human judgment and accountability remain at the centre of care.

Q. Where are the easiest wins for hospitals starting now?
A. Three domains where data is strong and ROI is measurable: ambient documentation, imaging assists (e.g., fracture or stroke detection), and triage. Each has documented gains and a clear KPI.

Q. What are the biggest risks?
A. Data bias and inequitable outcomes, privacy leakage, alert fatigue from poor integration, and accountability gaps when an AI recommendation contributes to a decision.

Q. How is AI used in drug discovery?
A. By simulating molecular interactions across vast chemical, biological, and trial datasets to predict promising compounds, shortening discovery timelines from years to months. Generative AI also produces synthetic datasets for rare diseases and models personalized treatment responses.

Q. What is precision medicine?
A. An approach that customizes treatment to patient subgroups defined by data — genetics, biomarkers, clinical history - rather than applying a single protocol to everyone. AI surfaces the subgroups by finding patterns hypothesis-based research would miss.

About the author 

Prof. May El Barachi, Dean of Computer Science and Full Professor at the University of Wollongong in Dubai. Academic leader in digital innovation, applied AI and industry-aligned technology education.

Step back to the bigger picture: read our article on the future of intelligence